These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23270674)

  • 1. The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure.
    Jani PP; Narayan H; Ng LL
    Peptides; 2013 Feb; 40():72-6. PubMed ID: 23270674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma urotensin in human systolic heart failure.
    Ng LL; Loke I; O'Brien RJ; Squire IB; Davies JE
    Circulation; 2002 Dec; 106(23):2877-80. PubMed ID: 12460864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma urotensin II in heart failure.
    Richards AM; Nicholls MG; Lainchbury JG; Fisher S; Yandle TG
    Lancet; 2002 Aug; 360(9332):545-6. PubMed ID: 12241661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides.
    Mallamaci F; Cutrupi S; Pizzini P; Tripepi G; Zoccali C
    J Nephrol; 2005; 18(6):727-32. PubMed ID: 16358231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.
    Nakayama T; Hirose T; Totsune K; Mori N; Maruyama Y; Maejima T; Minagawa K; Morimoto R; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Kohzuki M; Takahashi K; Imai Y
    Peptides; 2008 May; 29(5):801-8. PubMed ID: 18314225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.
    Dschietzig T; Bartsch C; Pregla R; Zurbrügg HR; Armbruster FP; Richter C; Laule M; Romeyke E; Neubert C; Voelter W; Baumann G; Stangl K
    Regul Pept; 2002 Dec; 110(1):33-8. PubMed ID: 12468107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Cutrupi S; Pizzini P; Malatino L
    Kidney Int; 2006 Apr; 69(7):1253-8. PubMed ID: 16508659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.
    Sugo T; Murakami Y; Shimomura Y; Harada M; Abe M; Ishibashi Y; Kitada C; Miyajima N; Suzuki N; Mori M; Fujino M
    Biochem Biophys Res Commun; 2003 Oct; 310(3):860-8. PubMed ID: 14550283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.
    Mallamaci F; Cutrupi S; Pizzini P; Tripepi G; Zoccali C
    Am J Hypertens; 2006 May; 19(5):505-10. PubMed ID: 16647624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the origin of the biased agonism associated with the urotensin II receptor activation.
    Brancaccio D; Merlino F; Limatola A; Yousif AM; Gomez-Monterrey I; Campiglia P; Novellino E; Grieco P; Carotenuto A
    J Pept Sci; 2015 May; 21(5):392-9. PubMed ID: 25694247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.
    Billard E; Hébert TE; Chatenet D
    J Med Chem; 2018 Oct; 61(19):8707-8716. PubMed ID: 30183282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of urotensin II and URP.
    Leprince J; Chatenet D; Dubessy C; Fournier A; Pfeiffer B; Scalbert E; Renard P; Pacaud P; Oulyadi H; Ségalas-Milazzo I; Guilhaudis L; Davoust D; Tonon MC; Vaudry H
    Peptides; 2008 May; 29(5):658-73. PubMed ID: 17931747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.
    Chatenet D; Folch B; Feytens D; Létourneau M; Tourwé D; Doucet N; Fournier A
    J Med Chem; 2013 Dec; 56(23):9612-22. PubMed ID: 24251366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation.
    Billard E; Létourneau M; Hébert TE; Chatenet D
    Biochem Pharmacol; 2017 Nov; 144():100-107. PubMed ID: 28784291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.
    Mori N; Hirose T; Nakayama T; Ito O; Kanazawa M; Imai Y; Kohzuki M; Takahashi K; Totsune K
    Peptides; 2009 Feb; 30(2):400-8. PubMed ID: 18955095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
    Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
    Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Circulating Urotensin II and Urotensin II-Related Peptide-Generating Enzymes in the Human Plasma Fraction Cohn IV-4.
    Schuster R; Steffen P; Dreyer B; Rohn S; Schlüter H; Riedner M
    J Proteome Res; 2021 Dec; 20(12):5368-5378. PubMed ID: 34734734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.